ZBH Stock: Price, Earnings History and SEC Filings
Zimmer Biomet Holdings, Inc. (ZBH) last traded at $94.52, down 3.03% on the latest session and up 6.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $2.07 against an analyst estimate of $2.01, a beat of 3.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ZBH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $2.07 | $2.01 | +2.99% |
| Mar 2026 | Apr 28, 2026 | $2.09 | $1.86 | +12.37% |
| Dec 2025 | Feb 10, 2026 | $2.42 | $2.38 | +1.68% |
| Sep 2025 | Nov 5, 2025 | $1.90 | $1.88 | +1.06% |
ZBH beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How ZBH reacts to earnings
Across its last 8 earnings releases, ZBH moved 7.6% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-05 | Before open | +2.45% |
| 2026-04-28 | Before open | -10.57% |
| 2026-02-10 | Before open | +1.86% |
| 2025-11-05 | Before open | -15.15% |
| 2025-08-07 | Before open | +7.99% |
| 2025-05-05 | Before open | -11.62% |
| 2025-02-06 | Before open | -5.14% |
| 2024-10-30 | Before open | +5.71% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
ZBH financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $8.2B | $705M | $1.5B | 8.6% | $3.55 |
| 2024 | $7.7B | $904M | $1.3B | 11.8% | $4.43 |
| 2023 | $7.4B | $1.0B | $1.3B | 13.8% | $4.88 |
| 2022 | $6.9B | $231M | – | 3.3% | $1.10 |
| 2021 | $6.8B | $402M | $1.4B | 5.9% | $1.91 |
| 2020 | $6.1B | -$139M | $1.1B | -2.3% | $-0.67 |
| 2019 | $8.0B | $1.1B | $1.4B | 14.2% | $5.47 |
| 2018 | $7.9B | -$379M | $1.6B | -4.8% | $-1.86 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ZBH
- 8-K · Sep 8, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 5, 2026Other events, Financial statements and exhibits
- 10-Q · Aug 5, 2026
- 8-K · Aug 5, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 29, 2026Material agreement, Agreement terminated, New financial obligation
- 8-K · May 27, 2026Shareholder vote, Financial statements and exhibits
- 8-K · May 12, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · May 1, 2026
- 8-K · Apr 28, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Apr 28, 2026Results of operations, Financial statements and exhibits
Insider filing activity
ZBH insiders filed 12 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ZBH news
- Zimmer Biomet (ZBH) Stock May Be A Bargain Despite Robot Surgery PushOct 31, 2026 · finance.yahoo.com
- Stryker Sinks 5% on Q3 Miss and Guidance Cut: “Fall Short of Our Expectations”Oct 30, 2026 · tikr.com
- Zimmer Biomet Holdings IncOct 30, 2026 · 247wallst.com
- Zimmer Biomet Gears Up to Report Q3 Earnings: What's in the Cards?Oct 29, 2026 · finance.yahoo.com
- Zimmer Biomet to Preview the Next Era of Intelligent Orthopedic Surgery at AAHKS 2026Oct 29, 2026 · finance.yahoo.com
- Is Intuitive Surgical Stock's Market Price Justified?Oct 29, 2026 · trefis.com
- Why Zimmer Biomet (ZBH) is a top value stock for the long termOct 29, 2026 · msn.com
- If Intuitive Surgical Stock Looks Expensive, You Need To Read ThisOct 26, 2026 · trefis.com
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH) is a US-listed public company on NYSE. The SEC classifies its business as Orthopedic Prosthetic & Surgical Appliances & Supplies. It is incorporated in DE. Its fiscal year ends in December.